| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0300-595X(80)80023-5 |
| P8608 | Fatcat ID | release_nmhbig3e55fjjh7ejwrkbpyvfy |
| P698 | PubMed publication ID | 6998606 |
| P2093 | author name string | Hahn TJ | |
| P2860 | cites work | Myopathy associated with anticonvulsant osteomalacia | Q28362792 |
| Iatrogenic osteomalacia in epileptic children. A controlled therapeutic trial | Q30986247 | ||
| Fractures in Still's disease | Q33570803 | ||
| Effect of cortisone treatment on the active transport of calcium by the small intestine | Q34062147 | ||
| 25-hydroxycholecalciferol stimulation of muscle metabolism | Q34483799 | ||
| Phenobarbital-induced alterations in vitamin D metabolism | Q34495396 | ||
| Pseudohypoparathyroidism with paradoxical increase in hypocalcaemic seizures due to long-term anticonvulsant therapy | Q36809628 | ||
| Effects of anticonvulsants and inactivity on bone disease in epileptics | Q36810095 | ||
| Interaction of Diphenylhydantoin (Phenytoin) and Phenobarbital with Hormonal Mediation of Fetal Rat Bone Resorption In Vitro | Q37030882 | ||
| Glucocorticoid receptors and actions in subpopulations of cultured rat bone cells. Mechanism of dexamethasone potentiation of parathyroid hormone-stimulated cyclic AMP production | Q37037616 | ||
| Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration | Q37041053 | ||
| Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose | Q37045709 | ||
| Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids | Q39520371 | ||
| Disordered mineral metabolism produced by ketogenic diet therapy | Q39693081 | ||
| Effects of phenobarbital and diphenylhydantoin on acute vitamin D3 toxicity in the rat | Q40132242 | ||
| Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus | Q40194056 | ||
| Intestinal Calcium-Binding Protein and Calcium Absorption in Cortisol-Treated Chicks: Effects of Vitamin D3and 1,25-Dihydroxyvitamin D3* | Q40230055 | ||
| Anticonvulsant drug-induced osteomalacia: Alterations in mineral metabolism and response to vitamin D3 administration | Q40244147 | ||
| Cortisol enhancement of PTH-stimulated cyclic AMP accumulation in cultured fetal rat long bone rudiments | Q40273189 | ||
| Effects of cortisone administration on the metabolism and localization of 25-hydroxycholecalciferol in the rat. | Q40372264 | ||
| Anticonvulsant osteomalacia induced in the rat by diphenylhydantoin | Q40676062 | ||
| Effect of diphenylhydantoin on the metabolism of dexamethasone | Q43820962 | ||
| Vitamin D metabolites and bone mineralization in man | Q45101807 | ||
| 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol: conversion impaired by systemic metabolic acidosis | Q45155457 | ||
| Incidence of Anticonvulsant Osteomalacia and Effect of Vitamin D: Controlled Therapeutic Trial | Q53451016 | ||
| Natural and Synthetic Sources of Circulating 25-Hydroxyvitamin D in Man | Q53864646 | ||
| The effect of phenytoin on parathyroid extract and 25-hydroxycholecalciferol-induced bone resorption: adenosine 3, 5 cyclic monophosphate production. | Q54174099 | ||
| Effects of acetazolamide and parathyroidectomy on renal transport of sodium, calcium, and phosphate. | Q54615042 | ||
| Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy | Q54732571 | ||
| Altered Calcium Metabolism in Epileptic Children on Anticonvulsants | Q55174462 | ||
| Effect of Glucocorticoids on Function of the Parathyroid Glands in Man | Q66909807 | ||
| Glucocorticoids regulate the concentration of 1,25-dihydroxycholecalciferol receptors in bone | Q67017643 | ||
| The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia | Q67020921 | ||
| Vitamin D Prophylaxis and the Lowered Incidence of Fractures in Anticonvulsant Rickets and Osteomalacia | Q67064911 | ||
| The Effect of Anticonvulsant Therapy on Serum Levels of 25-Hydroxy-Vitamin D, Calcium, and Parathyroid Hormone | Q67356499 | ||
| Fracture healing in rats treated with diphenylhydantoin (Dilantin) | Q67453274 | ||
| Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs | Q67560857 | ||
| Acetazolamide-accelerated anticonvulsant osteomalacia | Q67593591 | ||
| Cortisol stimulation of parathyroid hormone secretion by rat parathyroid glands in organ culture | Q67775863 | ||
| 25-Hydroxycholecalciferol: high affinity substrate for hepatic cytochrome P-450 | Q67851104 | ||
| Effects of prednisone on vitamin D metabolism in man | Q68583820 | ||
| Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs | Q68648875 | ||
| Vitamin D-dependency rickets in institutionalized, mentally retarded children on long term anticonvulsant therapy. II. The response to 25-hydroxycholecalciferol and to vitamin D2 | Q68670357 | ||
| Diphenylhydantoin: effects on calcium metabolism in the chick | Q68675880 | ||
| Effect of phenobarbital administration on the subcellular distribution of vitamin D3-3H in rat liver | Q68685626 | ||
| Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass | Q68801560 | ||
| Influence of Diphenylhydantoin and Phenobarbital on Intestinal Calcium Transport in the Rat | Q69009107 | ||
| Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults | Q69205393 | ||
| Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients | Q69570339 | ||
| Development of anticonvulsant osteomalacia in epileptic patients on phenytoin treatment | Q69811841 | ||
| Bone formation in hypercortisonism | Q71563185 | ||
| Disturbance of Calcium Metabolism by Anticonvulsant Drugs | Q71574040 | ||
| Corticosteroid and bone | Q71626372 | ||
| Osteoporosis of rheumatoid arthritis: Influence of age, sex and corticosteroids | Q72288729 | ||
| Effect of Chronic Phenobarbital Treatment on the Liver Microsomal Metabolism and Uterotropic Action of 17β-Estradiol1 | Q72333855 | ||
| Quantitative microradiographic study of bone remodeling in Cushing's syndrome | Q72825712 | ||
| Vertebral fractures resulting from prolonged cortisone and corticotropin therapy | Q73618646 | ||
| Roentgenologic changes of the skeletal system in Cushing's syndrome | Q78298286 | ||
| The action of corticosteroids on the renal reabsorption of calcium | Q78811299 | ||
| P433 | issue | 1 | |
| P921 | main subject | vitamin D | Q175621 |
| P304 | page(s) | 107-127 | |
| P577 | publication date | 1980-03-01 | |
| P1433 | published in | Clinics in Endocrinology and Metabolism | Q5133864 |
| P1476 | title | Drug-induced disorders of vitamin D and mineral metabolism | |
| P478 | volume | 9 |
| Q37592009 | A review of drug-induced hypocalcemia |
| Q67275834 | Adverse effects of antiarrhythmic drugs |
| Q72395734 | Anticonvulsant drug therapy in human pregnancy: Effects on serum concentrations of vitamin D metabolites in maternal and cord blood |
| Q70212935 | Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover |
| Q34207030 | Biochemical markers to survey bone turnover |
| Q67475365 | Bone histomorphometry in Cushing's syndrome |
| Q36601372 | Bone mineral content after renal transplantation. Placebo-controlled prospective study with 1,25-dihydroxy vitamin D3. |
| Q38530297 | Bone status after long-term anticonvulsant therapy in epileptic patients: evaluation using quantitative ultrasound of calcaneus and phalanges |
| Q70228950 | Calcium-oxalate-crystal-induced bone disease |
| Q72858714 | Corticosteroid-induced osteoporosis |
| Q37990943 | Corticosteroid-induced osteoporosis: an update for dermatologists |
| Q70133368 | Decreased bone density in severely handicapped children and adults, with reference to the influence of limited mobility and anticonvulsant medication |
| Q48821290 | Disorders of calcium metabolism |
| Q40147819 | Drug-Induced Electrolyte Disorders |
| Q34198478 | Effect of ovariectomy and prednisolone on bone mineral content in rats: evaluation by single photon absorptiometry and radiogrammetry |
| Q44420536 | Effects of Chronic Administration of Zonisamide, an Antiepileptic Drug, on Bone Mineral Density and Their Prevention With Alfacalcidol in Growing Rats |
| Q73923258 | Epilepsy, broken bones, and fatty stools |
| Q69570419 | Factors associated with the biochemical changes in vitamin D and calcium metabolism in institutionalized patients with epilepsy |
| Q67235495 | Glucocorticoid regulation of 1,25(OH)2-vitamin D3 receptors in cultured mouse bone cells |
| Q70292527 | Influence of glucocorticoids on calcium absorption in different segments of the rat intestine |
| Q70515538 | Interrelation of cortisone and 1,25 dihydroxycholecalciferol on intestinal calcium and phosphate absorption |
| Q44844968 | Loss of seizure control due to anticonvulsant-induced hypocalcemia |
| Q70284823 | Metabolic Bone Disease And Vitamin D Deficiency In Crohn's Disease |
| Q42523222 | Monomeric serum calcitonin and bone turnover during anticonvulsant treatment and in congenital hypothyroidism |
| Q72009136 | Musculoskeletal complications of systemic lupus erythematosus in the hopkins lupus cohort: An update |
| Q33643771 | Musculoskeletal manifestations of osteomalacia: report of 26 cases and literature review |
| Q28079443 | Nutritional Aspects of Treatment in Epileptic Patients |
| Q70450401 | On the pathogenesis of anticonvulsant-drug-induced alterations of calcium metabolism |
| Q33625019 | Osteopenia in cerebral palsy |
| Q36881409 | Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluation |
| Q40472413 | Osteoporosis: Clinical Features, Prevention, and Treatment |
| Q38293890 | Physiologic and metabolic aspects of anticonvulsants |
| Q35550964 | Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice |
| Q36856628 | Pseudohypoparathyroidism type Ia manifesting as intractable epilepsy in a 23-year-old female |
| Q84522928 | Recurrent symptomatic hypocalcemia during rifampicin therapy for brucellosis |
| Q70752913 | Reflex sympathetic dystrophy syndrome and barbiturates. A study of 25 cases treated with barbiturates compared with 124 cases treated without barbiturates |
| Q35856028 | Rickets-vitamin D deficiency and dependency |
| Q70990000 | Sequential changes in mineral metabolism and serum vitamin D metabolite concentrations produced by phenobarbital administration in the rat |
| Q70357513 | The Vitamin D Family Revisited |
| Q36362197 | The association of hypovitaminosis d with the metabolic syndrome is independent of the degree of obesity. |
| Q34254779 | Treatment issues for women with epilepsy |
| Q72903490 | Vitamin D 1980--a stocktaking (author's transl) |
| Q28069486 | Vitamin D3 for the Treatment of Epilepsy: Basic Mechanisms, Animal Models, and Clinical Trials |
Search more.